Stay updated on Nivolumab and Axitinib in RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Axitinib in RCC Clinical Trial page.

Latest updates to the Nivolumab and Axitinib in RCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA new revision label v3.5.0 was added and the previous label v3.4.3 was removed.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check53 days agoChange DetectedAn administrative update adds a new revision tag (v3.4.2) and removes older notices (lapse in government funding notice and v3.4.1), with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedAdded a site-wide notice about government funding lapse and NIH Clinical Center status at the top of the page. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check68 days agoChange DetectedShow glossary option added; capitalization tweaks to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'; and the revision version updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check82 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3 in the study documents section, with no changes to core study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Axitinib in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Axitinib in RCC Clinical Trial page.